Key points are not available for this paper at this time.
Introduction Regeneron Pharmaceuticals Inc. L. Qi: None. R.B. Reinert: None. Funding National Institutes of Health (K08DK129719, T32DK007245)
Share your take
Add a clinician perspective alongside expert commentary.
Zhu et al. (Fri,) studied this question.